No insider purchase over the last 90 days. The latest, by 김선영, was filed 11 Jan 2024.
Helixmith Co., Ltd: what insiders have been doing
This page follows insider dealings at Helixmith Co., Ltd as filed with DART (FSS), a company from the Health Care sector. Between 1 November 2025 and 1 November 2026, 2 insiders published 4 filings.
No insider bought on the market over the period, while 1 insider filed 2 sales. No amount is published for 2 filings, which the totals therefore leave out.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 4 filings here. The full history, which starts in 2021, counts 6 purchases against 13 sales.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -27.6%Entry ₩3,930 · Close at T+365 ₩2,845
- -55.3%Entry ₩10,770 · Close at T+365 ₩4,810
- -52.9%Entry ₩20,050 · Close at T+365 ₩9,450
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 416,873 sharesKRXDART:20260504000305
- ●Executives0DART
- ●Executives0DART
- 117,843 sharesKRXDART:20260123000376
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 13,500 sharesKRXDART:20240111000010Canonical exit: 3 Apr 2024 (T+90)
- 4,000 shares@ ₩4,001.875100.0% of flowShareKRXDART:20240111000011Canonical exit: 7 Apr 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 936,066 sharesKRXDART:20230216001268Canonical exit: 17 May 2023 (T+90)
- 936,066 shares@ ₩10,683.00100.0% of flowShareKRXDART:20230216001306Canonical exit: 16 May 2023 (T+90)
- 42,536 sharesKRXDART:20230207000461
- 2,006,031 sharesKRXDART:20230207000459Canonical exit: 8 May 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 117,843 sharesKRXDART:20220513001079
- 117,843 sharesKRXDART:20220513001085
25 of 59 declarations
About Helixmith Co., Ltd
Helixmith is a biotechnology company focused on developing gene therapies to treat serious diseases. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
